logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Samumed, LLC


USPTO Granted Patents = 115



Trademarks = 1

Forward Citations = 2,496

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Sunil Kumar Kc (106 out of 124 patents)

silverMedal John Hood (96 out of 121 patents)

bronzeMedal David Mark Wallace (86 out of 118 patents)

4.  Chandramouli Chiruta (53 out of 58 patents)

5.  Jianguo Cao (53 out of 84 patents)

6.  Gopi Kumar Mittapalli (17 out of 23 patents)

7.  Chi Ching Mak (16 out of 33 patents)

8.  Venkataiah Bollu (15 out of 26 patents)

9.  Charlene F Barroga (13 out of 16 patents)

10.  Brian Walter Eastman (13 out of 33 patents)

11.  Brian Joseph Hofilena (10 out of 14 patents)

12.  Joseph Timothy Marakovits (7 out of 20 patents)

13.  Sunil Kumar K C (7 out of 23 patents)

14.  Luis A Dellamary (4 out of 74 patents)

15.  Yusuf Yazici (3 out of 5 patents)


Core Competencies:
Wnt Signaling Pathway
Indazole Inhibitors
Isoquinolin Carboxamides
Gamma-Diketones
Therapeutic Uses
Anti-Inflammatory Compounds
Osteoarthritis Treatment
Single-Dose Injectable Formulations
Heteroaryl Compounds
Macrocycles
Carboxamides
Pyrazolo Compounds

115 patents:

1. 11034682 - Gamma-diketones as wnt/β-catenin signaling pathway activators (2021-06-15),
2. 10981909 - Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide (2021-04-20),
3. 10947228 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof (2021-03-16),
4. 10947217 - Isoquinolin-3-YL carboxamides and preparation and use thereof (2021-03-16),
5. 10934297 - 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof (2021-03-02),
6. 10899757 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof (2021-01-26),
7. 10882860 - Treatment of osteoarthritis (2021-01-05),
8. 10806726 - Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors (2020-10-20),
9. 10759799 - Indazole containing macrocycles and therapeutic uses thereof (2020-09-01),
10. 10758523 - Single-dose, ready-to-use injectable formulations (2020-09-01),
11. 10744128 - 6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof (2020-08-18),
12. 10703748 - Diazanaphthalen-3-yl carboxamides and preparation and use thereof (2020-07-07),
13. 10669240 - 5-substituted indazole-3-carboxamides and preparation and use thereof (2020-06-02),
14. 10654832 - 3-(benzoimidazol-2-YL)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof (2020-05-19),
15. 10653688 - 6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof (2020-05-19),
Samumed is a pharmaceutical company focused on advancing regenerative medicine and targeted therapies to address chronic diseases. They utilize their proprietary small molecule platform to develop treatments for conditions such as osteoarthritis, alopecia, degenerative disc disease, and several others. With a commitment to scientific innovation, Samumed aims to revolutionize the field of regenerative medicine and improve patients' lives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
115 Patents

#49 in San Diego, CA

#746 in California

#3,211 in US

#6,689 in the World

...
San Diego, CA, United States of America

Samumed, LLC

Forward Citations = 2,496

19 inventors:

goldMedal Sunil Kumar Kc (106 out of 124 patents)

silverMedal John Hood (96 out of 121 patents)

bronzeMedal David Mark Wallace (86 out of 118 patents)

4.  Chandramouli Chiruta (53 out of 58 patents)

5.  Jianguo Cao (53 out of 84 patents)

Please report any incorrect information to support@idiyas.com
Loading…